Last reviewed · How we verify
Risperidone with Clozapine — Competitive Intelligence Brief
phase 1
Small molecule
Live · refreshed every 30 min
Target snapshot
Risperidone with Clozapine (Risperidone with Clozapine) — Shanghai Mental Health Center.
Comparator set
| Drug | Generic | Sponsor | Phase | Class | Target | Approval / PDUFA |
|---|---|---|---|---|---|---|
| Risperidone with Clozapine TARGET | Risperidone with Clozapine | Shanghai Mental Health Center | phase 1 |
Recent regulatory actions (last 90 days)
Upcoming PDUFA dates (next 180 days)
Patent timeline (forward window)
Sponsor landscape
Subscribe to ongoing alerts
Push every new event for this competitive set into your RSS reader, IFTTT/Zapier workflow, or email digest:
- Risperidone with Clozapine CI watch — RSS
- Risperidone with Clozapine CI watch — Atom
- Risperidone with Clozapine CI watch — JSON
- Risperidone with Clozapine alone — RSS
Cite this brief
Drug Landscape (2026). Risperidone with Clozapine — Competitive Intelligence Brief. https://druglandscape.com/ci/risperidone-with-clozapine. Accessed 2026-05-17.
Build your own brief
Pick any drug + add comparators:
https://druglandscape.com/ci/{slug}— auto-detected competitorshttps://druglandscape.com/ci/{slug}?vs=drug1,drug2,drug3— explicit comparators- Brand names auto-resolve:
/ci/keytruda→ 301 →/ci/pembrolizumab